Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5694986 | Fertility and Sterility | 2017 | 23 Pages |
Abstract
The short-term efficacy in terms of improvement of sexual function and safety of transdermal T in naturally and surgically menopausal women affected by HSDD either on or not on estrogen progestin hormone therapy is evident from this systematic review. The use of transdermal T is associated with increase in androgenic adverse events such as acne but is not associated with any serious adverse events.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Chiara M.B.B.S., Jyotsna M.D., M.R.C.O.G., Parimalam M.D., M.R.C.O.G., Luca M.D., M.R.C.O.G., Haitham M.D., M.R.C.O.G., Nick M.R.C.O.G.,